Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa

Clinical trial NCT07170917 · RECRUITING

Trial details

NCT number: NCT07170917
Sponsor: Sanofi
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hidradenitis Suppurativa

Start date: 2025-11-06
Primary completion: 2027-02-09
Enrollment: 208

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.